ACC 2019: What the Latest Procedural Advancements Might Mean for Medtech

Posted by Eric Sin on April 16, 2019

Just a couple of weekends ago, I sat in the crowd at the American College of Cardiology (ACC) conference in New Orleans as Dr. Leon and Dr. Reardon presented on transcatheter aortic valve replacement (TAVR) trials in low-surgical-risk aortic stenosis (AS) patients. These findings will not only raise paradigm-shifting questions for the AS market but also prompt discussion around some common industry dilemmas, especially for markets where effective but expensive procedure options become more widely accepted for broader patient populations.


>
Read More

What Medtech Companies Can Learn From Apple's Virtual Clinical Study

Posted by Kate Templeton on March 21, 2019

The American College of Cardiology’s (ACC) Scientific Session and Expo, held March 16-18 in New Orleans, kicked off Saturday morning with the initial results of the much-anticipated Apple Heart Study. For those who keep pace with the fast-moving tech world, I’m sure it felt like an eternity since the study had been announced. But by healthcare standards, the study went quickly and accomplished something unthinkable: It enrolled a breathtaking 419,297 individuals in eight months using a novel, entirely virtual study design.


>
Read More

Generating Value Through Digital and Connected Health Analytics

Posted by Vishal Srivastava on February 13, 2019

"Digitization" has been disrupting several parts of the economy, including the medical devices industry. Beyond the initial hype, we see several programs beginning to show real results and that look promising for improving quality and decreasing healthcare costs. The industry is beginning to look at digital health solutions to drive differentiation as it moves toward focusing on healthcare value and outcomes.


>
Read More

It's Time for Medtech to Turn Digital

Posted by Pete Masloski on May 10, 2018

The digital health industry has had its share of hype over the years. Remember when fitness trackers were the next greatest thing, and billions of dollars were flooding through venture capitalists into new digital health startups that were going to make us all eat better and exercise more? Well, we know how that turned out: Fitbit recently announced its seventh consecutive quarter of year-over-year revenue declines as well as several new partnerships designed to bake their wearables into more comprehensive health management programs. It turns out that it takes a lot more than a clever device to change behavior. 


>
Read More

How to Reduce the Cost of Sales Without Impacting Revenue

Posted by Andy Kach on October 24, 2017

Internal profit pressures are sending medtech companies in search of ways to reduce their cost of sales. In most cases, medical device prices are dropping alongside revenue because of two factors: Providers are negotiating stronger contract positions and using or stocking medical devices more efficiently. To maintain the same level of profitability, many medical device firms are considering or testing out lower-cost sales deployment options to reach the same level of success that field sales teams have achieved in the past.


>
Read More